BS
Boston Scientific Corp cut its RNXT stake below 5%
Boston Scientific Corp reported owning 0% of RenovoRx, Inc. (RNXT) in a Schedule 13G filed Nov 6, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
Cookies show us what works. Privacy
Cookies show us what works. Privacy
Boston Scientific Corp reported owning 0% of RenovoRx, Inc. (RNXT) in a Schedule 13G filed Nov 6, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.